CLINICAL-EVALUATION OF TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) - PROCEEDINGS OF A SYMPOSIUM HELD IN BARCELONA ON SEPTEMBER 24, 1989 - PREFACE

被引：0
|
作者：
STENMAN, UH [1 ]
BALLESTA, A [1 ]
TORRE, GC [1 ]
机构：
[1] SALITA AL,I-17027 PIETRA LIGURE,ITALY
来源：
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION | 1991年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 33 条
  • [31] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) IN PATIENTS WITH COLORECTAL-CANCER - A COMPARISON WITH CEA, CA-50 AND CA-242
    PASANEN, P
    ESKELINEN, M
    KULJU, A
    PENTTILLA, I
    JANATUINEN, E
    ALHAVA, E
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1995, 55 (02): : 119 - 124
  • [32] Association of tumor-associated trypsin inhibitor (TATI) expression with molecular markers, pathologic features and clinical outcomes of urothelial carcinoma of the urinary bladder
    Patschan, Oliver
    Shariat, Shahrokh F.
    Chade, Daher C.
    Karakiewicz, Pierre I.
    Ashfaq, Raheela
    Lotan, Yair
    Hotakainen, Kristina
    Stenman, Ulf-Hakan
    Bjartell, Anders
    WORLD JOURNAL OF UROLOGY, 2012, 30 (06) : 785 - 794
  • [33] Association of tumor-associated trypsin inhibitor (TATI) expression with molecular markers, pathologic features and clinical outcomes of urothelial carcinoma of the urinary bladder
    Oliver Patschan
    Shahrokh F. Shariat
    Daher C. Chade
    Pierre I. Karakiewicz
    Raheela Ashfaq
    Yair Lotan
    Kristina Hotakainen
    Ulf-Håkan Stenman
    Anders Bjartell
    World Journal of Urology, 2012, 30 : 785 - 794
1234